Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
8.03
-0.05 (-0.68%)
Apr 26, 2024, 10:50 AM EDT - Market open

Ironwood Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Revenue
442.74410.6413.75389.52428.41346.64298.28273.96149.5676.44
Upgrade
Revenue Growth (YoY)
7.83%-0.76%6.22%-9.08%23.59%16.21%8.88%83.18%95.66%234.06%
Upgrade
Cost of Revenue
0003.1423.883319.412.2417.6525.58
Upgrade
Gross Profit
442.74410.6413.75386.39404.54313.64278.87271.72131.9150.85
Upgrade
Selling, General & Admin
158.31115.99111.13140172.45219.68231.18173.28125.25118.33
Upgrade
Research & Development
116.0944.2770.4188.06115.04101.0688.15139.49108.75101.89
Upgrade
Other Operating Expenses
1,1140-0.0415.38-3.08174.626.210.9800
Upgrade
Operating Expenses
1,388160.26181.49243.45284.42495.36325.54313.75233.99220.22
Upgrade
Operating Income
-945.43250.34232.26142.94120.12-181.72-46.67-42.04-102.09-169.37
Upgrade
Interest Expense / Income
21.637.631.1529.4836.637.7236.3739.1531.121.17
Upgrade
Other Expense / Income
-48.31-9.680.454.662.0262.9333.890.529.49-0.92
Upgrade
Pretax Income
-918.75252.42200.66108.8621.51-282.37-116.94-81.71-142.67-189.62
Upgrade
Income Tax
83.4977.36-327.792.69000000
Upgrade
Net Income
-1,002.24175.07528.45106.1821.51-282.37-116.94-81.71-142.67-189.62
Upgrade
Net Income Growth
--66.87%397.71%393.73%------
Upgrade
Shares Outstanding (Basic)
155154162159156153149145142137
Upgrade
Shares Outstanding (Diluted)
155186164161156153149145142137
Upgrade
Shares Change
-16.57%13.32%2.34%2.97%2.22%2.44%2.80%1.95%3.91%18.09%
Upgrade
EPS (Basic)
-6.451.133.260.670.14-1.85-0.78-0.56-1.00-1.39
Upgrade
EPS (Diluted)
-6.450.963.210.660.14-1.85-0.78-0.56-1.00-1.39
Upgrade
EPS Growth
--70.09%386.36%371.43%------
Upgrade
Free Cash Flow
183.15273.63261.63166.993.8-69.67-103.42-29.92-110.83-159.11
Upgrade
Free Cash Flow Per Share
1.181.771.611.050.02-0.46-0.69-0.21-0.78-1.16
Upgrade
Gross Margin
100.00%100.00%100.00%99.19%94.43%90.48%93.49%99.18%88.20%66.53%
Upgrade
Operating Margin
-213.54%60.97%56.13%36.70%28.04%-52.42%-15.65%-15.35%-68.26%-221.58%
Upgrade
Profit Margin
-226.37%42.64%127.72%27.26%5.02%-81.46%-39.20%-29.83%-95.40%-248.07%
Upgrade
Free Cash Flow Margin
41.37%66.64%63.23%42.87%0.89%-20.10%-34.67%-10.92%-74.11%-208.16%
Upgrade
Effective Tax Rate
-30.65%-163.36%2.47%------
Upgrade
EBITDA
-895.55261.44233.33141.963.69-232.67-67.91-31.3-99.94-156.12
Upgrade
EBITDA Margin
-202.28%63.67%56.39%36.43%14.87%-67.12%-22.77%-11.42%-66.83%-204.25%
Upgrade
Depreciation & Amortization
1.581.421.523.565.5811.9712.6611.2611.6312.33
Upgrade
EBIT
-897.12260.02231.81138.3458.11-244.64-80.57-42.56-111.57-168.45
Upgrade
EBIT Margin
-202.63%63.33%56.03%35.51%13.56%-70.58%-27.01%-15.53%-74.60%-220.38%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).